Target intelligence / Profile preview

Ribosomal protein S3 pseudogene 4 (RPS3P4)

Target: RPS3P4
Molecular classification: Other

Overview

Ribosomal protein S3 pseudogene 4 (RPS3P4) is a processed pseudogene derived from the ribosomal protein S3 (RPS3) gene. It does not encode a functional protein and is classified as a pseudogene, meaning it is a non-functional genomic DNA sequence that arises from a functional gene ancestor[4][6]. RPS3P4 should not be considered a drug target or therapeutic receptor, enzyme, transporter, or similar biologically active target. There is no evidence for disease association, protein expression, or drug interaction, and it lacks characterized biological functions.

Other names: RPS3_1_652RPS3P4

Beyond the preview

Go deeper on Ribosomal protein S3 pseudogene 4 (RPS3P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein S3 pseudogene 4 (RPS3P4).

Explore the full profile